• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌骨转移患者发生及预后的同质和异质风险因素。

The homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients with bone metastasis.

作者信息

Wang Ben, Chen Lijie, Huang Chongan, Lin Jialiang, Pan Xiangxiang, Shao Zhenxuan, Hu Sunli, Zhang Xiaolei, Wang Xiangyang

机构信息

Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, Zhejiang, China.

Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou 325027, Zhejiang, China.

出版信息

J Bone Oncol. 2019 Jul 9;17:100251. doi: 10.1016/j.jbo.2019.100251. eCollection 2019 Aug.

DOI:10.1016/j.jbo.2019.100251
PMID:31372332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6661364/
Abstract

PURPOSE

To analyse the homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients diagnosed with bone metastasis (BM) by using the Surveillance, Epidemiology, and End Results (SEER) database.

PATIENTS AND METHODS

The medical records of lung cancer patients with or without bone metastasis were identified in the SEER database between 2010 and 2015. A multivariate logistic regression analysis was performed to identify risk factors, and a multivariate Cox regression was used to determine the prognostic effects of every variable on survival.

RESULTS

In total, 34,585 eligible patients from the SEER database were included in the analysis. Male gender and metastasis to the liver were factors that were both positively associated with a risk for the development and prognosis of bone metastasis in patients with lung cancer. Younger age, poor tumour differentiation grade, higher N stage (N3), adenocarcinoma and metastasis to the brain were all positively correlated with a risk of occurrence of BM, but these factors were not correlated with an unfavourable prognosis. Age, race, marital status, tumour size and pathologic type were independent risk factors for the prognosis of bone metastasis.

CONCLUSION

The morbidity of bone metastasis in lung cancer patients is dismal, with a rate of 25.9%. The findings of this study estimate the homogeneous and heterogeneous risk factors for the occurrence and prognosis of bone metastasis in lung cancer patients, which may provide clinical guidelines for physicians.

摘要

目的

利用监测、流行病学和最终结果(SEER)数据库分析诊断为骨转移(BM)的肺癌患者发生和预后的同质和异质风险因素。

患者与方法

在SEER数据库中识别2010年至2015年间有或无骨转移的肺癌患者的病历。进行多因素逻辑回归分析以识别风险因素,并使用多因素Cox回归确定每个变量对生存的预后影响。

结果

总共34585名符合条件的患者纳入了SEER数据库分析。男性和肝转移是与肺癌患者骨转移发生和预后风险均呈正相关的因素。年龄较小、肿瘤分化程度差、N分期较高(N3)、腺癌和脑转移均与BM发生风险呈正相关,但这些因素与不良预后无关。年龄、种族、婚姻状况、肿瘤大小和病理类型是骨转移预后的独立风险因素。

结论

肺癌患者骨转移的发病率令人沮丧,为25.9%。本研究结果估计了肺癌患者骨转移发生和预后的同质和异质风险因素,可为医生提供临床指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a55/6661364/9352fafc2ecb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a55/6661364/6f83f0ef6906/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a55/6661364/f863e89d2de1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a55/6661364/5e03a1087b23/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a55/6661364/9352fafc2ecb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a55/6661364/6f83f0ef6906/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a55/6661364/f863e89d2de1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a55/6661364/5e03a1087b23/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a55/6661364/9352fafc2ecb/gr3.jpg

相似文献

1
The homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients with bone metastasis.肺癌骨转移患者发生及预后的同质和异质风险因素。
J Bone Oncol. 2019 Jul 9;17:100251. doi: 10.1016/j.jbo.2019.100251. eCollection 2019 Aug.
2
The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer.前列腺癌患者骨转移发病及预后的同质和异质风险因素。
Cancer Manag Res. 2018 Jun 22;10:1639-1646. doi: 10.2147/CMAR.S168579. eCollection 2018.
3
Analysis of Homogeneous and Heterogeneous Factors for Bone Metastasis in Esophageal Cancer.分析食管癌骨转移的同质和异质因素。
Med Sci Monit. 2019 Dec 10;25:9416-9425. doi: 10.12659/MSM.920483.
4
Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients.探讨同质和异质危险因素对非小细胞肺癌患者骨转移发生率和生存结局的影响。
J Cancer Res Clin Oncol. 2019 Mar;145(3):737-746. doi: 10.1007/s00432-018-02826-7. Epub 2019 Jan 2.
5
Homogeneous and heterogeneous risk and prognostic factors for lung metastasis in colorectal cancer patients.结直肠癌患者肺转移的同质和异质风险及预后因素。
BMC Gastroenterol. 2022 Apr 18;22(1):193. doi: 10.1186/s12876-022-02270-5.
6
Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.基于人群的研究:初诊浸润性导管乳腺癌患者骨转移的风险因素、预后因素和列线图。
BMC Cancer. 2020 Nov 25;20(1):1145. doi: 10.1186/s12885-020-07635-1.
7
Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database.新诊断结直肠癌骨转移模式:SEER数据库的真实世界分析
Int J Colorectal Dis. 2019 Mar;34(3):533-543. doi: 10.1007/s00384-018-3213-5. Epub 2019 Jan 8.
8
Racial disparities in bone metastasis patterns and targeted screening and treatment strategies in newly diagnosed lung cancer patients.肺癌初诊患者骨转移模式的种族差异及靶向筛查和治疗策略。
Ethn Health. 2022 Feb;27(2):329-342. doi: 10.1080/13557858.2020.1734775. Epub 2020 Mar 28.
9
Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.同质和异质风险因素对肝细胞癌患者脑转移发生率和预后的影响。
Ann Palliat Med. 2020 Sep;9(5):2654-2667. doi: 10.21037/apm-20-1012. Epub 2020 Aug 31.
10
Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China.基于 SEER 的研究与中国一家本地医院的研究:前列腺癌患者的预后与骨转移模式。
Sci Rep. 2020 Jun 4;10(1):9104. doi: 10.1038/s41598-020-64073-6.

引用本文的文献

1
Lung Adenocarcinoma With Bone Metastases: Clinicogenomic Profiling and Insights Into Prognostic Factors.伴有骨转移的肺腺癌:临床基因组分析及对预后因素的见解
Cancer Control. 2025 Jan-Dec;32:10732748251325587. doi: 10.1177/10732748251325587. Epub 2025 Mar 24.
2
Distant metastatic patterns in young and old non-small cell lung cancer patients: A dose‒response analysis based on SEER population.年轻和老年非小细胞肺癌患者的远处转移模式:基于监测、流行病学和最终结果(SEER)数据库人群的剂量反应分析
Heliyon. 2024 Aug 22;10(17):e36657. doi: 10.1016/j.heliyon.2024.e36657. eCollection 2024 Sep 15.
3
Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition).

本文引用的文献

1
The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: a SEER-based study.非小细胞肺癌及其变异型患者多器官转移的预后价值:一项基于 SEER 的研究。
J Cancer Res Clin Oncol. 2018 Sep;144(9):1835-1842. doi: 10.1007/s00432-018-2702-9. Epub 2018 Jul 12.
2
Sex differences in lung cancer survival: long-term trends using population-based cancer registry data in Osaka, Japan.肺癌生存率的性别差异:利用日本大阪基于人群的癌症登记数据的长期趋势
Jpn J Clin Oncol. 2017 Sep 1;47(9):863-869. doi: 10.1093/jjco/hyx094.
3
Prognostic significance of sites of extrathoracic metastasis in patients with non-small cell lung cancer.
《中国肺癌骨转移诊疗专家共识(2022年版)》
J Natl Cancer Cent. 2023 Aug 19;3(4):256-265. doi: 10.1016/j.jncc.2023.08.004. eCollection 2023 Dec.
4
Development of a predictive model to predict postoperative bone metastasis in pathological I-II non-small cell lung cancer.预测病理I-II期非小细胞肺癌术后骨转移的预测模型的开发。
Transl Lung Cancer Res. 2024 May 31;13(5):998-1009. doi: 10.21037/tlcr-23-866. Epub 2024 May 20.
5
Construction of a predictive model for bone metastasis from first primary lung adenocarcinoma within 3 cm based on machine learning algorithm: a retrospective study.基于机器学习算法构建的首个 3 cm 内原发性肺腺癌骨转移预测模型:一项回顾性研究。
PeerJ. 2024 Mar 14;12:e17098. doi: 10.7717/peerj.17098. eCollection 2024.
6
Development and Validation of a Prognostic Nomogram for Lung Adenocarcinoma: A Population-Based Study.基于人群的肺腺癌预后列线图的建立和验证。
J Healthc Eng. 2022 Dec 10;2022:5698582. doi: 10.1155/2022/5698582. eCollection 2022.
7
Bone metastasis after stage IIIA non-small cell lung cancer: risks and prognosis.IIIA期非小细胞肺癌后的骨转移:风险与预后
J Bras Pneumol. 2022 Nov 4;48(5):e20220211. doi: 10.36416/1806-3756/e20220211.
8
Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis.列线图预测胰腺癌骨转移的风险和预后因素:基于人群的分析。
Front Endocrinol (Lausanne). 2022 Mar 9;12:752176. doi: 10.3389/fendo.2021.752176. eCollection 2021.
9
Predictive factors, preventive implications, and personalized surgical strategies for bone metastasis from lung cancer: population-based approach with a comprehensive cancer center-based study.肺癌骨转移的预测因素、预防意义及个性化手术策略:基于人群的方法与基于综合癌症中心的研究
EPMA J. 2022 Jan 10;13(1):57-75. doi: 10.1007/s13167-022-00270-9. eCollection 2022 Mar.
10
The incidence and mortality trends of bone lymphoma in the United States: An analysis of the Surveillance, Epidemiology, and End Results database.美国骨淋巴瘤的发病率和死亡率趋势:监测、流行病学和最终结果数据库分析
J Bone Oncol. 2020 Jul 17;24:100306. doi: 10.1016/j.jbo.2020.100306. eCollection 2020 Oct.
非小细胞肺癌患者胸外转移部位的预后意义
J Thorac Dis. 2017 Jul;9(7):1903-1910. doi: 10.21037/jtd.2017.06.117.
4
Clinical Characteristics and Prognostic Factors in Bone Metastases from Lung Cancer.肺癌骨转移的临床特征和预后因素。
Med Sci Monit. 2017 Aug 24;23:4087-4094. doi: 10.12659/msm.902971.
5
Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years.加利福尼亚州肺癌发病率按种族/族裔、组织学、性别和社区社会经济地位的变化趋势:一项跨越28年的分析。
Lung Cancer. 2017 Jun;108:140-149. doi: 10.1016/j.lungcan.2017.03.014. Epub 2017 Mar 30.
6
Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis.脊柱转移瘤患者的预后因素:一项系统评价和荟萃分析。
Spine J. 2017 May;17(5):689-708. doi: 10.1016/j.spinee.2016.12.003. Epub 2016 Dec 14.
7
Dynamic contrast-enhanced MRI to predict response to vinorelbine-cisplatin alone or with rh-endostatin in patients with non-small cell lung cancer and bone metastases: a randomised, double-blind, placebo-controlled trial.动态对比增强 MRI 预测长春瑞滨联合顺铂或联合 rh-endostatin 治疗非小细胞肺癌伴骨转移患者的疗效:一项随机、双盲、安慰剂对照研究。
Lancet. 2016 Oct;388 Suppl 1:S95. doi: 10.1016/S0140-6736(16)32022-0.
8
Lung cancer: current therapies and new targeted treatments.肺癌:当前疗法与新的靶向治疗。
Lancet. 2017 Jan 21;389(10066):299-311. doi: 10.1016/S0140-6736(16)30958-8. Epub 2016 Aug 27.
9
Prognostic effect of liver metastasis in lung cancer patients with distant metastasis.肺癌远处转移患者肝转移的预后影响
Oncotarget. 2016 Aug 16;7(33):53245-53253. doi: 10.18632/oncotarget.10644.
10
Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.晚期非小细胞肺癌患者癌性恶病质的生活质量与生存调查——日本晚期非小细胞肺癌患者营养与生活质量调查研究
Support Care Cancer. 2016 Aug;24(8):3473-80. doi: 10.1007/s00520-016-3156-8. Epub 2016 Mar 22.